4.2 Article

Probiotics and prebiotics in Crohn's disease therapies

Journal

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.bpg.2016.02.002

Keywords

Probiotics; Prebiotics; Synbiotics; Inflammatory bowel disease; Crohn's disease; VSL#3; Sacchromyces boullardi; Bifidobacterium; Lactobacillus

Ask authors/readers for more resources

Therapeutic manipulation of gut microbiota has proven valuable in the management of ulcerative colitis and pouchitis. Despite some similarities among the various inflammatory bowel conditions, the probiotics investigated thus far seem to confer little benefit in Crohn's disease. In this review, we aim to bring together the evidence available on the clinical effect of probiotics and prebioltics in Crohn's disease patients, and to clarify the place of probiotic treatment in current Crohn's therapeutic regimens. (C) 2016 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available